Targeting FGFR2 Could Offer Hope in Preventing or Delaying KRAS-Mutated Pancreatic Cancers
FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development In a groundbreaking study published in the journal Cancer Research, researchers have uncovered ...
